Browsing by author "Douglas, Mark"
Sort by:
Title A-Z
-
Australian tertiary care outcomes of entecavir monotherapy in treatment naive patients with chronic hepatitis B
Fahrtash-Bahin, Farzan; Kariyawasam, Viraj C; Gray, Timothy; Byth, Karen; George, Jacob; Douglas, MarkPublished 2013-01-01Abstract AIM: To evaluate the long-term treatment outcomes of entecavir monotherapy in treatment naive patients in an Australian tertiary care setting. METHODS: A retrospective analysis of treatment naive patients receiving ...Open AccessArticle -
Cross-genotypic examination of hepatitis C virus polymerase inhibitors reveals a novel mechanism of action for thumb binders
Eltahla, Auda A; Tay, Enoch; Douglas, Mark; White, Peter APublished 2014-01-01Open AccessArticle -
Determination of interactions between tegument proteins of herpes simplex virus type 1
Vittone, Valerio; Diefenbach, Eve; Triffett, Damian; Douglas, Mark; Cunningham, Anthony; Diefenbach, RussellPublished 2005-01-01Open AccessArticle -
Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response
Read, Scott A; Tay, Enoch; Shahidi, Mahsa; O'Connor, Kate; Booth, David; George, Jacob; Douglas, MarkPublished 2015-01-01Treatment of chronic hepatitis C virus (HCV) infection is evolving rapidly with the development of novel direct acting antivirals (DAAs), however viral clearance remains intimately linked to the hepatic innate immune system. ...Open AccessArticle -
Hepatitis C Virus Induces the Cannabinoid Receptor 1
van der Poorten, David; Shahidi, Mahsa; Tay, Enoch; Sesha, Jayshree; Tran, Kayla; McLeod, Duncan; Milliken, J; Ho, Vicki; Hebbard, Lionel; Douglas, Mark; George, JacobPublished 2010-01-01Background: Activation of hepatic CB1 receptors (CB1) is associated with steatosis and fibrosis in experimental forms of liver disease. However, CB1 expression has not been assessed in patients with chronic hepatitis C ...Open AccessArticle -
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
Eslam, Mohammed; Hashem, Ahmed M; Leung, Reynold; Romero-Gomez, Manuel; Berg, Thomas; Dore, Gregory; Chan, Henry L K; Irving, William; Sheridan, David; Abate, Maria; Mangia, Alessandra; Weltman, Martin; Bugianesi, Elisabetta; Spengler, Ulrich; Shaker, Olfat; Fischer, Janett; Mollison, Lindsay; Cheng, Wendy; Powell, Elizabeth; Nattermann, Jacob; Riordan, Stephen; McLeod, Duncan; Armstrong, Nicola J.; Douglas, Mark; Liddle, Christopher; Booth, David R.; George, Jacob; Ahlenstiel, Golo; International Hepatitis C Genetics Consortium (IHCGC)Published 2015-01-01Open AccessArticle -
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
Thabet, Khaled; Asimakopoulos, Anastasia; Shojaei, Maryam; Romero-Gomez, Manuel; Mangia, Alessandra; Irving, William L.; Berg, Thomas; Dore, Gregory J.; Grønbæk, Henning; Sheridan, David; Abate, Maria; Bugianes, Elisabetta; Weltman, Martin; Mollison, Lindsay; Cheng, Wendy; Riordan, Stephen; Fischer, Janett; Spengler, Ulrich; Nattermann, Jacob; Wahid, Ahmed; Rojas, Angela; White, Rose; Douglas, Mark; McLeod, Duncan; Powell, Elizabeth; Liddle, Christopher; van der Poorten, David; George, Jacob; Eslam, Mohammed; International Liver Disease Genetics ConsortiumPublished 2016-01-01Open AccessArticle
Sort by:
Title A-Z